Together with a higher expression of C18:1 in DBS samples of T1DM + patients, these data demonstrated that could be evident a suppression of fatty acid β-oxidation via STAT3 activation mediated by EVs that might reflect the toxic function of “liver lesion” highlighted in the previous paragraph. The gene discussed is STAT3; the disease is type 1 diabetes mellitus.